UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051911
Receipt number R000059224
Scientific Title Investigation of Inference of Anaerobic Threshold Levels by Double Products Using a Non-Hypertensive Blood Pressure Measurement Wearable Device
Date of disclosure of the study information 2023/08/16
Last modified on 2024/02/14 12:54:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of Inference of Anaerobic Threshold Levels by Double Products Using a Wearable Device

Acronym

Investigation of Inference of Anaerobic Threshold Levels by Double Products Using a Wearable Device

Scientific Title

Investigation of Inference of Anaerobic Threshold Levels by Double Products Using a Non-Hypertensive Blood Pressure Measurement Wearable Device

Scientific Title:Acronym

Investigation of Inference of Anaerobic Threshold Levels by Double Products Using a Non-Hypertensive Blood Pressure Measurement Wearable Device

Region

Japan


Condition

Condition

no

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to confirm that the AT values obtained by CPX for healthy adults are consistent with the DPBP values obtained by the Arblet wearable device.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate the equivalence of exercise intensity in AT and DPBP from Arblet wearable devices during the exercise test.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

cardiopulmonary exercise test with a wearable device

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

healthy adults

Key exclusion criteria

Patients with absolute contraindications to cardiopulmonary exercise test
Pregnant or possibly pregnant
Those who refused to participate in the study
Persons who are deemed by the physician to be inappropriate for participation in the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Ebihara

Organization

Tohoku University Graduate School of Medicine

Division name

Internal Medicine and Rehabilitation Science

Zip code

980-8574

Address

1-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi Prefecture

TEL

022-717-7353

Email

satoru.ebihara.c4@tohoku.ac.jp


Public contact

Name of contact person

1st name taiki
Middle name
Last name katsumata

Organization

Tohoku University Graduate School of Medicine

Division name

Internal Medicine and Rehabilitation Science

Zip code

980-8574

Address

1-1 Seiryo-cho, Aoba-ku, Sendai City, Miyagi Prefecture

TEL

022-717-7353

Homepage URL


Email

katsumata.taiki.q4@dc.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 06 Month 16 Day

Date of IRB

2023 Year 08 Month 29 Day

Anticipated trial start date

2023 Year 09 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry

2025 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 15 Day

Last modified on

2024 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059224


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name